Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized N-acetylcysteine for sputum quality and microbiologic yield in suspected lower respiratory tract infection
ACTRN12607000301460Phase 3Completed
- Sponsor
- Austin Health
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in pulmonary infection (2 arms), sponsored by Austin Health. Started Aug 2007; status: completed.
02
Drugs
acetylcysteine
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on ACTRN12607000301460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000301460.